We are live on ! Find out more
SI

Sava Infond Portfolio holdings

AUM $1.41B
1-Year Est. Return 69.95%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+69.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$705M
AUM Growth
-$35.9M
Cap. Flow
+$2.94M
Cap. Flow %
0.42%
Top 10 Hldgs %
43.11%
Holding
239
New
17
Increased
65
Reduced
66
Closed
9

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.08M
2
MU icon
Micron Technology
MU
+$7.51M
3
PLTR icon
Palantir
PLTR
+$6.12M
4
AMD icon
Advanced Micro Devices
AMD
+$5.96M
5
XOM icon
ExxonMobil
XOM
+$4.63M

Top Sells

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$8.35M
2
MRVL icon
Marvell Technology
MRVL
+$7.56M
3
TSM icon
TSMC
TSM
+$5.8M
4
AMAT icon
Applied Materials
AMAT
+$5.41M
5
AAPL icon
Apple
AAPL
+$4.77M

Sector Composition

Rank Sector Weight
1 Technology 46.02%
2 Communication Services 11.22%
3 Healthcare 9.66%
4 Consumer Discretionary 7.14%
5 Financials 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BN icon
101
Brookfield
BN
$102B
$991K 0.14%
24,490
-1,640
-6% -$72.7K
LEN icon
102
Lennar Class A
LEN
$20.4B
$968K 0.14%
11,150
VALE icon
103
Vale
VALE
$62.9B
$955K 0.14%
60,000
MCD icon
104
McDonald's
MCD
$188B
$939K 0.13%
3,020
-170
-5% -$54.2K
AMGN icon
105
Amgen
AMGN
$203B
$932K 0.13%
2,650
-195
-7% -$69.5K
KLAC icon
106
KLA
KLAC
$275B
$928K 0.13%
6,300
-4,800
-43% -$702K
MDT icon
107
Medtronic
MDT
$107B
$925K 0.13%
10,680
-580
-5% -$55.6K
RPRX icon
108
Royalty Pharma
RPRX
$26.1B
$905K 0.13%
18,860
-4,340
-19% -$190K
VZ icon
109
Verizon
VZ
$194B
$872K 0.12%
17,380
+12,000
+223% +$556K
SYK icon
110
Stryker
SYK
$127B
$871K 0.12%
2,650
FMX icon
111
Fomento Económico Mexicano
FMX
$43.3B
$848K 0.12%
7,640
KSA icon
112
iShares MSCI Saudi Arabia ETF
KSA
$647M
$795K 0.11%
20,000
JAZZ icon
113
Jazz Pharmaceuticals
JAZZ
$15.9B
$794K 0.11%
4,200
NVO
114
Novo Nordisk
NVO
$216B
$762K 0.11%
20,725
INFY icon
115
Infosys
INFY
$45B
$743K 0.11%
55,000
+15,000
+38% +$235K
DIS icon
116
Walt Disney
DIS
$165B
$732K 0.1%
7,600
-10,275
-57% -$1.09M
NTRA icon
117
Natera
NTRA
$37.5B
$700K 0.1%
3,500
VRTX icon
118
Vertex Pharmaceuticals
VRTX
$121B
$692K 0.1%
1,550
-20
-1% -$9.33K
LMND icon
119
Lemonade
LMND
$4.62B
$689K 0.1%
11,000
+3,200
+41% +$221K
CVS icon
120
CVS Health
CVS
$137B
$679K 0.1%
9,450
WIT icon
121
Wipro
WIT
$18.5B
$678K 0.1%
320,000
B
122
Barrick Mining
B
$62.2B
$673K 0.1%
16,500
+10,500
+175% +$485K
CMG icon
123
Chipotle Mexican Grill
CMG
$40.8B
$669K 0.09%
20,900
BSAC icon
124
Banco Santander Chile
BSAC
$15.8B
$668K 0.09%
20,000
VLO icon
125
Valero Energy
VLO
$89.8B
$667K 0.09%
2,700
+1,600
+145% +$330K

Similar funds

Sava Infond's Q1 2026 Portfolio in Review

As of Q1 2026, Sava Infond held 239 positions worth $705M, down 4.8% from $741M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Sava Infond's Q1 2026 filing shows 17 new, 65 increased, 66 reduced and 9 closed positions. Its largest new stake was AstraZeneca: 41,890 shares worth $8.15M. The largest sale was ServiceNow, an estimated $8.35M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 49% a quarter earlier, followed by Communication Services and Healthcare.

  • Sava Infond's largest Q1 2026 buy was AstraZeneca: 41,890 shares worth $8.15M.
  • Sava Infond added most to Micron Technology in Q1 2026, an estimated $7.51M increase.
  • Sava Infond's biggest Q1 2026 reduction was ServiceNow, cutting an estimated $8.35M.
  • Sava Infond fully exited Pinterest in Q1 2026, selling an estimated $725K.
  • Sava Infond's ten largest holdings make up 43% of its $705M portfolio in Q1 2026.
  • Sava Infond opened 17 new positions and closed 9 in Q1 2026.
  • Sava Infond's portfolio value fell 4.8% quarter-over-quarter to $705M.

Based on Sava Infond's 13F filing for Q1 2026, filed 11 May 2026.